KBL Merger
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KBL Merger and buy or sell other stocks, ETFs, and their options commission-free!About KBLM
ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.
CEOMcAndrew A. Rudisill
CEOMcAndrew A. Rudisill
Employees3
Employees3
HeadquartersPalm Beach, Florida
HeadquartersPalm Beach, Florida
Founded2016
Founded2016
Employees3
Employees3
KBLM Key Statistics
Market cap2.15M
Market cap2.15M
Price-Earnings ratio-0.32
Price-Earnings ratio-0.32
Dividend yield—
Dividend yield—
Average volume1.68M
Average volume1.68M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$174.60
52 Week high$174.60
52 Week low$6.58
52 Week low$6.58
Stock Snapshot
KBL Merger(KBLM) stock is priced at $3.56, giving the company a market capitalization of 2.15M. It carries a P/E multiple of -0.32.
During the trading day, KBL Merger(KBLM) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.68M.
Over the past 52 weeks, KBL Merger(KBLM) stock has traded between a high of $174.60 and a low of $6.58.
Over the past 52 weeks, KBL Merger(KBLM) stock has traded between a high of $174.60 and a low of $6.58.
People also own
Based on the portfolios of people who own KBLM. This list is generated using Robinhood data, and it’s not a recommendation.